Apellis Pharmaceuticals(us:APLS)

22.68

+3.70%

Updated on 2025-04-02

Open:21.77
Close:22.68
High:23.77
Low:21.77
Prev Close:21.87
Volume:4.91M
Turnover:111.54M
Turnover Ratio:3.91%
Shares:125.52M
MarketCap:2.85B

About

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
Address:100 5th Avenue

Market Movers